As more understanding about the critical role of the gut microbiome in human health becomes available, its connection to many systems in the body continues to emerge. Many people don’t realize that the health of the gut microbiome may play a significant role in depression, including major depressive disorder, and anxiety, including generalized anxiety disorder or social anxiety disorder.^1-3

Mental health is a major healthcare challenge worldwide, with estimates that 11% of all people will experience major depressive disorder at some point in their lives.^3,4 Major depressive disorder is a condition that doesn’t always respond well to treatment; up to 30% of patients do not respond to antidepressants, indicating a need for different types of interventions that healthcare providers can offer.⁴ There appears to be a dietary connection to mental health. Studies have found two to four times higher levels of anxiety and depression in people with inflammatory bowel disease (IBD), causing research interest in dysbiosis in the human gut microbiome and its role in mental health, including the interplay between inflammation, gut health, and the burden of managing a chronic disease. Researchers Moulton et al. in a review piece about neuro-immune reactions and IBD, explain that though depressive symptoms could arguably be linked to the burden and pain associated with the condition, there is evidence of what they refer to as ‘inflammatory depression’ where the gut-brain axis, inflammation, and gut microbiome disturbances create the pathogenesis of depressive symptoms in this population.⁵  The connection between gut microbial imbalance and the pathogenesis of mental health problems suggests a connection between these systems, known as the gut-brain axis.^2,3,6

This gut-brain axis is a bidirectional communication system where the central nervous system, the enteric nervous system (residing in the gut), and the digestive tract interact and influence each other.⁷ Emerging evidence points to the gut microbiome affecting brain function and behavior through pathways that include immune modulation, neurotransmitter and hormone activity, and the stress response system.^2,4,7 A better understanding of these interactions could offer focus areas for healthcare providers to advise microbiome-supporting dietary changes that support mental health.

The Gut-Brain Axis and Mood
A key component of the gut-brain axis depends on the role of gut microbiota in producing neurotransmitters and other signaling molecules. Researchers have identified thirteen microbial taxa (a classification of the microorganisms) that are likely associated with depressive symptoms in a large cohort from the Rotterdam Study.⁸ The identified microbes are specifically involved in the production of neurotransmitters like glutamate, butyrate, serotonin, and gamma-aminobutyric acid (GABA), which play a role in the pathology of depression when imbalances occur.⁸Dopamine pathways, important for cognition, pleasure, and motivation among other mood-related functions, have a connection to the gut-brain axis with emerging research about specific genres of microbiota that play a role in both dopamine synthesis and breakdown.⁹ Researchers have also found that gut microbiome diversity was inversely associated with depressive symptoms, indicating that educating clients on ways to increase microbial diversity through dietary strategies is a place that healthcare providers could focus. For many people struggling with mood disorders, exploring strategies in addition to traditional medications can be empowering and offer hope.⁸ 

A study by Dong et al compared three groups: people with major depressive disorder (n=23), people with generalized anxiety disorder (n=21), and healthy control subjects (n=10), and found significant differences in microbial richness and diversity, especially between the generalized anxiety disorder group and healthy controls.¹⁰ The differences between the generalized anxiety disorder group and the control group were significant in several ways. Researchers found that certain types of bacteria tested significantly decreased in quantity, as well as others that significantly increased in both the generalized anxiety disorder group compared to controls and the generalized anxiety disorder group compared to the major depressive disorder group. For example, there were differences in the abundance of specific genera of bacteria such as lower levels of Sutterella and Fusicatenibacter in people with major depressive disorder compared to controls and lower levels of Fusicatenibacter and Christensenellaceae_R7_group in generalized anxiety disorder than in the controls.¹⁰ These researchers indicate that as more is learned about specific types and quantities of bacteria concerning conditions like major depressive disorder and generalized anxiety disorder, more targeted interventions and therapies could emerge.¹⁰

Another study by Butler et al explored the gut microbiome’s role in social anxiety disorder by comparing the microbiome compositions of individuals with social anxiety disorder (n=32) to healthy controls (n=32). They discovered that the overall microbiome composition in addition to several specific bacterial taxa, significantly differed between the two groups.¹¹ Of the 73 genres and 159 species identified, three genera and two species showed significant differences in abundance. For example, Anaeromassilibacillus and Gordonibacter were found at higher levels in participants with social anxiety disorder and Parasutterella was more abundant in control participants. This study is one of the first to demonstrate that the gut microbiome of people with social anxiety disorder is compositionally different from healthy controls and helps identify the specific bacterial genre. They advise more clinical studies to explore the mechanistic pathways behind this observance and larger, longitudinal studies on people with social anxiety disorder with the hopes of opening more treatment options for these patients in the future.¹¹ 

Study findings generally suggest that the gut microbiome may influence the development or exacerbation of mental health disorders, potentially offering new therapeutic targets through dietary or lifestyle interventions. A holistic approach that helps treat the underlying cause of depression and anxiety could provide a supportive strategy that healthcare providers can offer in addition to traditional therapies. There is a need for more studies that help determine which types of bacteria or shifts in microbiome diversity may be beneficial or problematic for people with depression and/or anxiety. 

Impact of Diet on the Gut Microbiome

Dietary Patterns
Studies have consistently shown that diets with higher intakes of vegetables, fruits, cereals, nuts, seeds, and pulses (legumes like beans or lentils) commonly found in dietary patterns like Mediterranean, Japanese, and Norwegian diets are associated with a lower incidence of depression.⁶ Conversely, the “Western”/Standard American dietary pattern, high in added sugars, refined grains, fried and ultra-processed foods, and red or processed meat, with low fruit and vegetable intake, is frequently associated with a higher incidence of depression.⁶

Micronutrients and Polyphenols

Certain micronutrients, including zinc, magnesium, selenium, iron, and vitamins B-6, B-12, D, E, and folate, are often found at low levels in people with depression.⁶ These deficiencies might negatively affect neurotransmitter production such as serotonin, brain signaling, and pathways involving inflammatory and oxidative stress.⁶ Diets rich in fruits and vegetables not only provide higher levels of these micronutrients but also contain potent antioxidant phytochemicals like vitamin C, polyphenols, and flavonoids, which studies show may offer antidepressant-like effects as well as anti-inflammatory activity.^12,13 Researchers have linked these compounds mechanistically to reduced depression through several regulating factors such as anti-inflammatory and reduced oxidative stress effects (including the ability to reduce neuroinflammation), and gut microbiome modulation through affecting the intestinal barrier function, influencing signaling pathways, and modifying the composition of gut microbes.^12,13

Dietary Fat 

Fatty acids, particularly polyunsaturated fatty acids (PUFAs) like omega-3 fats eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are essential for neural function and are incorporated into neural tissue. They are found in seafood including fish and shellfish, and microalgae, and also come in dietary supplement form. Studies on omega-3 fatty acids have shown that they may play a significant role in alleviating symptoms of depression in both dietary and supplemental forms. An observational study by Mehdi et al. following 165 patients with major depressive disorder found that supplementing with 500mg of omega-3s daily, particularly in combination with traditional antidepressants, resulted in a significant reduction in depressive symptoms compared to either treatment (omegas or medication) alone.¹⁴ Combination therapy improved depressive symptoms more effectively, highlighting the potential benefits of integrating omega-3 fatty acids via diet or supplementation for people with depression.

Prebiotics, Probiotics, and Synbiotics
Interventions including probiotics, prebiotics, and synbiotics (a combination of probiotics and prebiotics) could also play a role in reducing depressive symptoms in some patients. A large systematic review (n=43 studies) by Alli et al., found notable differences in the gut microbiome profiles between individuals with major depressive disorder and healthy controls, particularly regarding diversity and specific microbial taxa.⁴ The researchers observed that families Bifidobacteriaceae and Streptococcaceae, and Eggerthella and Streptococcus genera were increased in patients with major depressive disorder while the phylum Bacteroidetes, family Sutterellaceae, genus Coprococcus, and genus Faecalibacterium were decreased. The review highlighted that interventions with probiotics and synbiotics might offer modest benefits per validated rating scale scores in reducing depressive symptoms. Interestingly, prebiotics alone did not show a significant effect on depressive symptoms in this study.⁴ 

Takeaways for Providers 

As research continues to develop about the link between gut microbiome diversity and mental health disorders such as anxiety and depression, new avenues are opened for healthcare providers to integrate gut health considerations into mental health treatment plans, depending on their scope of practice. Given the emerging evidence, practitioners should consider gut health as a potentially contributing component of mental health. By incorporating strategies aimed at modulating the gut microbiome through dietary pattern adjustments – incorporating more vegetables, fruits, cereals, nuts, seeds, and beans/lentils – ensuring adequate micronutrient and polyphenol intake, or even considering probiotic and omega-3 fatty acid supplementation, healthcare providers can offer dietary options that may help to address both the psychological (social anxiety disorderness, irritability, apathy, or loss of interest in activities) and physiological aspects (fatigue, sleep disturbances, weight changes, changes in appetite) of mood disorders.¹⁵ An integrated approach not only aligns with growing scientific understanding but also enhances the scope of potential therapeutic interventions, helping to improve patient mental health outcomes.

References:

1. Limbana T, Khan F, Eskander N. Gut microbiome and depression: how microbes affect the way we think. Cureus. 2020;12(8).
2. Liu L, Wang H, Zhang H, et al. Toward a deeper understanding of gut microbiome in depression: the promise of clinical applicability. Advanced Science. 2022;9(35):2203707.
3. Medina-Rodriguez EM, Cruz AA, De Abreu JC, Beurel E. Stress, inflammation, microbiome and depression. Pharmacology Biochemistry and Behavior. 2023:173561.
4. Alli SR, Gorbovskaya I, Liu JC, Kolla NJ, Brown L, Müller DJ. The gut microbiome in depression and potential benefit of prebiotics, probiotics and synbiotics: a systematic review of clinical trials and observational studies. International journal of molecular sciences. 2022;23(9):4494.
5. Moulton CD, Pavlidis P, Norton C, Norton S, Pariante C, Hayee B, Powell N. Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?. Clinical & Experimental Immunology. 2019;197(3):308-18.
6. Bear TL, Dalziel JE, Coad J, Roy NC, Butts CA, Gopal PK. The role of the gut microbiota in dietary interventions for depression and anxiety. Advances in Nutrition. 2020;11(4):890-907.
7. Chakrabarti A, Geurts L, Hoyles L, et al. The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cellular and Molecular Life Sciences. 2022;79(2):80.
8. Radjabzadeh D, Bosch JA, Uitterlinden AG, et al. Gut microbiome-wide association study of depressive symptoms. Nature communications. 2022;13(1):7128.
9. Hamamah S, Aghazarian A, Nazaryan A, Hajnal A, Covasa M. Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling. Biomedicines. 2022 Feb 13;10(2):436.
10. Dong Z, Shen X, Hao Y, et al. Gut microbiome: a potential indicator for differential diagnosis of major depressive disorder and general anxiety disorder. Frontiers in Psychiatry. 2021;12:651536.
11. Butler MI, Bastiaanssen TF, Long-Smith C, et al. The gut microbiome in social anxiety disorder: evidence of altered composition and function. Translational psychiatry. 2023;13(1):95.
12. Winiarska-Mieczan A, Kwiecień M, Jachimowicz-Rogowska K, Donaldson J, Tomaszewska E, Baranowska-Wójcik E. Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders. International Journal of Molecular Sciences. 2023;24(3):2258.
13. Ali S, Corbi G, Maes M, Scapagnini G, Davinelli S. Exploring the impact of flavonoids on symptoms of depression: A systematic review and meta-analysis. Antioxidants. 2021;10(11):1644.
14. Mehdi S, Manohar K, Shariff A, et alOmega-3 fatty acids supplementation in the treatment of depression: An observational study. Journal of Personalized Medicine. 2023;13(2):224.
15. Remes O, Mendes JF, Templeton P. Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature. Brain Sci. 2021;11(12):1633.